Evidence map›Paper›PMID 23594147›Full record

ArticleBritish journal of pharmacology2013

5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor.

Amy S Newman, Nikolaos Batis, Gillian Grafton, Francesca Caputo, Catherine A Brady, Jeremy J Lambert, John A Peters, John Gordon, Keith L Brain, Andrew D Powell and 1 more

Open access · greenAbstract read
In one paragraph

Article in British journal of pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Structural basis for partial agonism in 5-HTNature structural & molecular biology · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Amy S NewmanCellular and Molecular Neuropharmacology Research Group, Clinical and Experimental Medicine, Medical School, University of Birmingham, Edgbaston, Birmingham, UK.
Nikolaos Batis
Gillian Grafton
Francesca Caputo
Catherine A Brady
Jeremy J Lambert
John A Peters
John Gordon
Keith L Brain
Andrew D Powell
Nicholas M Barnes
University of Birmingham · GBNinewells Hospital · GBUniversity of Dundee · GBUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe 5-HT₃ receptor is a ligand-gated ion channel that is modulated allosterically by various compounds including colchicine, alcohols and volatile anaesthetics. However the positive allosteric modulators (PAMs) identified to date have low affinity, which hinders investigation because of non-selective effects at pharmacologically active concentrations. The present study identifies 5-chloroindole (Cl-indole) as a potent PAM of the 5-HT₃ receptor. EXPERIMENTAL APPROACH: 5-HT₃ receptor function was assessed by the increase in intracellular calcium and single-cell electrophysiological recordings in HEK293 cells stably expressing the h5-HT₃A receptor and also the mouse native 5-HT₃ receptor that increases neuronal contraction of bladder smooth muscle. KEY

resultsCl-indole (1-100 μM) potentiated agonist (5-HT) and particularly partial agonist [(S)-zacopride, DDP733, RR210, quipazine, dopamine, 2-methyl-5-HT, SR57227A, meta chlorophenyl biguanide] induced h5-HT₃A receptor-mediated responses. This effect of Cl-indole was also apparent at the mouse native 5-HT₃ receptor. Radioligand-binding studies identified that Cl-indole induced a small (≈ twofold) increase in the apparent affinity of 5-HT for the h5-HT₃A receptor, whereas there was no effect upon the affinity of the antagonist, tropisetron. Cl-indole was able to reactivate desensitized 5-HT₃ receptors. In contrast to its effect on the 5-HT₃ receptor, Cl-indole did not alter human nicotinic α7 receptor responses. CONCLUSIONS AND IMPLICATIONS: The present study identifies Cl-indole as a relatively potent and selective PAM of the 5-HT₃ receptor; such compounds will aid investigation of the molecular basis for allosteric modulation of the 5-HT₃ receptor and may assist the discovery of novel therapeutic drugs targeting this receptor.

Indexed as

Allosteric RegulationAnimalsCalcium SignalingDrug Partial AgonismEvoked PotentialsHEK293 CellsHumansIndolesIn Vitro TechniquesMaleMiceMice, Inbred BALB CMuscle ContractionNerve Tissue ProteinsProtein SubunitsReceptors, Serotonin5-chloroindoleHTR3A protein, humanIndolesNerve Tissue ProteinsProtein SubunitsReceptors, SerotoninReceptors, Serotonin, 5-HT3Recombinant ProteinsSerotonin 5-HT3 Receptor AgonistsSerotonin 5-HT3 Receptor Antagonists

Identifiers

PMID23594147
PMCPMC3831704
OpenAlexW1602303853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.